Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
339
datasets available to search
ShareScore release 0.9.0
Dataset results
339 results for “CML”
French Study to Highlight the Unmet Treatment Needs of 3L+ CP-CML and With T315I-mutated CML Patients
ClinicalTrials.gov study NCT05619978. IPD Sharing: NO. Countries: 1. Publications: 0.
Real-World Evaluation of Patient Characteristics and Treatment Patterns Among Patients With CML-CP Treated With Asciminib
ClinicalTrials.gov study NCT06516029. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Hong Kong CML Registry
ClinicalTrials.gov study NCT03625583. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS
ClinicalTrials.gov study NCT00038831. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).
ClinicalTrials.gov study NCT06297161. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML)
ClinicalTrials.gov study NCT03421626. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase III Study of Compound Formula Realgar-Indigo Naturalis Plus Imatinib Versus Placebo Plus Imatinib in Adult CML-CP Patients With Ph+
ClinicalTrials.gov study NCT01755325. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on Imatinib
ClinicalTrials.gov study NCT00461929. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial Evaluating Nilotinib as Treatment for Newly Diagnosed CML Patients in Accelerated Phase.
ClinicalTrials.gov study NCT01605981. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Compliance: Role Emerges for Success in Chronic Myelogenous Leukaemia (CML): Evaluation aND Optimisation
ClinicalTrials.gov study NCT01243489. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Asciminib Used in Consolidation With Imatinib vs. Imatinib to Achieve TFR in CP-CML
ClinicalTrials.gov study NCT05413915. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Imatinib Response in Patients With Chronic Myeloid Leukemia (CML) in Function of Abl Polymorphisms
ClinicalTrials.gov study NCT01650467. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Nilotinib 300 mg BID in Newly Diagnosed CP-CML Patients to Verify Disappearance of CD34+/Lin-Ph+ Cells
ClinicalTrials.gov study NCT01856283. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy and Safety of Switching to Flumatinib Versus Dasatinib After Imatinib-related Low-grade Adverse Events in CML-CP Patients
ClinicalTrials.gov study NCT04933526. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.
ClinicalTrials.gov study NCT01066468. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radotinib as 3rd or Later Line Therapy in CP-CML
ClinicalTrials.gov study NCT02422719. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dose Reduced Dasatinib (70 mg Daily) as First-line Treatment for Newly Diagnosed CML-CP
ClinicalTrials.gov study NCT04155411. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Second STOP After Pioglitazone Priming in CML Patients
ClinicalTrials.gov study NCT02889003. IPD Sharing: YES. Countries: 1. Publications: 0.
Myeloid Mutations Register in R/R CML
ClinicalTrials.gov study NCT05080829. IPD Sharing: NO. Countries: 1. Publications: 0.
STA-9090 for Treatment of AML, CML, MDS and Myeloproliferative Disorders
ClinicalTrials.gov study NCT00858572. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.